Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: Reality or myth?

Cancer

Volumn 116, Issue 13, 2010, Pages 3251-3256

  Gripp, Stephan ^a   Mjartan, Sibylle ^b   Boelke, Edwin ^a   Willers, Reinhardt ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b SANA KLINIKUM OFFENBACH   (Germany)

Author keywords

Mortality; Neoplasm; Palliative care; Prognosis; Prospective studies; Quality of life; Radiotherapy; Terminally ill

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DYSPNEA; FEMALE; HUMAN; LEUKOCYTOSIS; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; TERMINALLY ILL PATIENT; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; DECISION MAKING; FEMALE; FORECASTING; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; PROGNOSIS; QUALITY OF LIFE; TIME FACTORS;

EID: 77954275609     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25112     Document Type: Article

References (42)

1. Addington-Hall J, McCarthy M. Dying from cancer: results of a national population-based investigation. Palliat Med. 1995;9:295-305.
2. Danjoux C, Chow E, Drossos A, et al. An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy. Support Care Cancer. 2006;14:38-43. (Pubitemid 43119595)
3. Azoulay E, Moreau D, Alberti C, et al. Predictors of shortterm mortality in critically ill patients with solid malignancies. Intensive Care Med. 2000;26:1817-1823. (Pubitemid 32009999)
4. Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage. 1992;7: 82-86.
5. Chuang RB, Hu WY, Chiu TY, Chen CY. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manage. 2004;28:115-122.
6. Morita T, Tsunoda J, Inoue S, Chihara S. The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer. 1999;7:128-133. (Pubitemid 29187559)
7. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999;17:231-239.
8. Yun YH, Heo DS, Heo BY, Yoo TW, Bae JM, Ahn SH. Development of terminal cancer prognostic score as an index in terminally ill cancer patients. Oncol Rep. 2001;8:795-800.
9. Chow E, Abdolell M, Panzarella T, et al. Predictive model for survival in patients with advanced cancer. J Clin Oncol. 2008;26:5863-5869.
10. Gripp S, Moeller S, Bolke E, et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol. 2007;25:3313-3320. (Pubitemid 47325618)
11. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45-56. (Pubitemid 13004473)
12. Maher EJ, Coia L, Duncan G, Lawton PA. Treatment strategies in advanced and metastatic cancer: differences in attitude between the USA, Canada and Europe. Int J Radiat Oncol Biol Phys. 1992;23:239-244.
13. Tang ST, Mccorkle R. Determinants of congruence between the preferred and actual place of death for terminally ill cancer patients. J Palliat Care. 2003;19:230-237. (Pubitemid 38121101)
14. Lamont EB, Christakis NA. Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to." JAMA. 2003;290:98-104.
15. Forster LE, Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med. 1988;148:2540-2543. (Pubitemid 19048169)
16. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320:469-472. (Pubitemid 30173113)
17. Glare P, Virik K, Jones M, et al. A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ. 2003;327:195.
18. Mackillop WJ, Quirt CF. Measuring the accuracy of prognostic judgments in oncology. J Clin Epidemiol. 1997;50:21-29.
19. Lynn J, Harrell F Jr, Cohn F, Wagner D, Connors AF Jr. Prognoses of seriously ill hospitalized patients on the days before death: implications for patient care and public policy. New Horiz. 1997;5:56-61. (Pubitemid 27081724)
20. Dahlstrand H, Hauksdottir A, Valdimarsdottir U, Furst CJ, Bergmark K, Steineck G. Disclosure of incurable illness to spouses: do they want to know? A Swedish population-based follow-up study. J Clin Oncol. 2008;26:3372-3379.
21. Maltoni M, Caraceni A, Brunelli C, et al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23:6240-6248.
22. Evans C, McCarthy M. Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet. 1985;325:1204-1206.
23. Reuben DB, Mor V, Hiris J. Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med. 1988;148:1586-1591.
24. Glare PA, Eychmueller S, McMahon P. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer. J Clin Oncol. 2004;22:4771-4776.
25. Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group Data. J Clin Oncol. 2005;23:175-183.
26. Chow E, Harth T, Hruby G, Finkelstein J, Wu J, Danjoux C. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol). 2001;13:209-218.
27. Allard P, Dionne A, Potvin D. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care. 1995;11:20-24.
28. Chow E, Abdolell M, Panzarella T, et al. Validation of a predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys. 2009;73:280-287.
29. Chow E, Abdolell M, Panzarella T, et al. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2009;73:1169-1176.
30. van den Hout WB, van der Linden YM, Steenland E, et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst Cancer Spectrum. 2003;95:222-229.
31. Roos DE, Turner SL, O'Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol. 2005;75:54-63. (Pubitemid 40616795)
32. Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97:798-804.
33. Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol. 2007;25:1423-1436. (Pubitemid 46706892)
34. Tveit KM, Guldvog I, Hagen S, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg. 1997;84:1130-1135. (Pubitemid 27359494)
35. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC. 15). Int J Radiat Oncol Biol Phys. 2002;54:719-728.
36. Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol. 1999;52:111-121.
37. Roos DE. Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol. 2000;56:315-322.
38. Crellin AM, Marks A, Maher EJ. Why don't British radiotherapists give single fractions of radiotherapy for bone metastases? Clin Oncol (R Coll Radiol). 1989;1:63-66.
39. van der Linden YM, Steenland E, van Houwelingen HC, et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. Radiother Oncol. 2006;78:245-253.
40. Lawton PA, Maher EJ. Treatment strategies for advanced and metastatic cancer in Europe. Radiother Oncol. 1991; 22:1-6.
41. Grabowski CM, Unger JA, Potish RA. Factors predictive of completion of treatment and survival after palliative radiation therapy. Radiology. 1992;184:329-332.
42. Williams MV, James ND, Summers ET, Barrett A, Ash DV. National survey of radiotherapy fractionation practice in 2003. Clin Oncol (R Coll Radiol). 2006;18:3-14.